Patrick Lamy, Senior VP, Commercial Strategy at Akero Therapeutics, Inc. (AKRO), sold 925 shares at $30.79 ($28K) on 2024-12-10, disclosed to the SEC on 2024-12-12.
Open-market sale of $28k AKRO by Senior VP, Commercial Strategy. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| AKRO | SELL | 2025-06-20 | $108K | — | Filing → |
| AKRO | SELL | 2025-06-12 | $50K | — | Filing → |
| AKRO | SELL | 2025-06-04 | $201K | — | Filing → |